论文部分内容阅读
目的对硝苯地平联合厄贝沙坦治疗2型糖尿病合并高血压的疗效进行分析。方法将该院2013年1月—2014年3月间收治的2型糖尿病合并高血压患者94例分为观察组47例以及对照组47例,其中观察组采取硝苯地平联合厄贝沙坦进行治疗,对照组仅采取硝苯地平进行治疗。对比两组患者的治疗效果。结果观察组总有效率为92.59%,对照组为89.36%,观察组总有效率要明显高于对照组,两组患者比较差异有统计学意义(P<0.05),治疗后两组患者血糖均有所下降,两组比较差异无统计学意义(P>0.05)。结论硝苯地平联合厄贝沙坦治疗2型糖尿病合并高血压具有较好的疗效,值得临床推广。
Objective To analyze the curative effect of nifedipine combined with irbesartan on type 2 diabetes with hypertension. Methods A total of 94 patients with type 2 diabetes mellitus complicated with hypertension admitted to our hospital from January 2013 to March 2014 were divided into observation group (n = 47) and control group (n = 47). The observation group was treated with nifedipine and irbesartan Treatment, the control group was treated with nifedipine only. Compare the treatment effect of two groups of patients. Results The total effective rate was 92.59% in the observation group and 89.36% in the control group. The total effective rate in the observation group was significantly higher than that in the control group, with significant difference between the two groups (P <0.05) The difference between the two groups was not statistically significant (P> 0.05). Conclusion Nifedipine combined with irbesartan in the treatment of type 2 diabetes mellitus with hypertension has good curative effect and is worthy of clinical promotion.